Safety and Tolerability of AZD5148 in Japanese Participants

NCT06639997 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridioides Difficile Infection

Interventions

DRUG: AZD5148
DRUG: Placebo

Sponsor

AstraZeneca